Another clinical study indicates that raised HbA1c can also contribute to NAFLD progression either directly by stimulating a receptor protein RAGE (receptor for advanced glycation end-products) or indirectly by promoting hypoxia and suppressing nitric oxide release14. This evidence concerns the gene ENG and metabolic dysfunction-associated steatotic liver disease.